Novo Nordisk A/S (NVO) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Novo Nordisk A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
14.10
Strong
WeakModerateStrong
P/B Ratio
7.45
Weak
WeakModerateStrong
Earnings Yield
7.09%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
52.79%
Strong
WeakModerateStrong
Operating Margin
41.30%
Strong
WeakModerateStrong
Net Profit Margin
33.14%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
6.43%
Moderate
WeakModerateStrong
Net Income Growth
1.43%
Weak
WeakModerateStrong
EPS Growth
1.72%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
0.80
Weak
WeakModerateStrong
Quick Ratio
0.57
Weak
WeakModerateStrong
Asset Turnover
0.57x
Moderate
WeakModerateStrong
Inventory Turnover
1.18x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.01%
Weak
WeakModerateStrong
EV / Free Cash Flow
53.45x
Weak
WeakModerateStrong
Net Debt / EBITDA
0.70x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.023
Strong
WeakModerateStrong
Return on Invested Capital
29.53%
Strong
WeakModerateStrong
Cash Conversion Cycle
274.83 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for NVO.
View Financial Statements